AAPG
Ascentage Pharma Group International
$18.50
+0.54 (+3.01%)
At close · Jul 2
Market Cap
$1.73B
Shares
373,322,192
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$18.50
Open$18.47
Day$18.00–18.50
52W$16.36–48.45
Avg vol 30d17K
Short int783 · 0.0% float · 1.0d
Short vol43%
DataJan 2025–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−31% below
−
Price vs 50-day avg
−6% below
◦
RSI (14)
53 · neutral
+
MACD trend
positive
−
52-week position
7% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $20 › 200d $27 — 200d above 50d
−
Institutional flow
-42% holders QoQ
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.00% of float · ▼ -33.5% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
7 holders — near 1-yr low, contrarian setup
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−31% below
Bearish
Price vs 50-day avg
−6% below
Bearish
RSI (14)
53 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
7% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $20 › 200d $27 — 200d above 50d
Institutional flow
Distributing
-42% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.00% of float · ▼ -33.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
7 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
52-wk low $16
Now $19 · 7%
52-wk high $48
vs 200-day avg -31%
vs 50-day avg -6%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AAPG
this stock
Ascentage Pharma Group International
|
$1.73B | -29.5% | — | — | 0.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AAPG | +8.5% | +3.5% | -33.7% | +5.4% | -29.5% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +7.1% | +4.8% | -41.7% | +5.6% | -38.7% |